Eptinezumab for the treatment of migraine.
Valerio SpuntarelliAndrea NegroMichelangelo LucianiEnrico BentivegnaPaolo MartellettiPublished in: Expert opinion on biological therapy (2021)
Eptinezumab had good results in several trials, making this molecule a promising migraine preventive drug. Although preclinical and clinical studies showed a significant efficacy, there are no data on the use of Eptinezumab during pregnancy or breastfeeding. There are still some knowledge limits about its pharmacokinetics and metabolism. This is a matter of concern that should be addressed in future studies.